AlphaValue/Baader Europe on Monday upgraded pharmaceutical giant AstraZeneca (AZN.L, AZN.ST) to add from reduce and reduced its price target to 150.20 pounds sterling from 150.21 pounds.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)